If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Brand Management and Product Leadership » Product Marketing and Innovation
Download FREE Excerpt
17 Info Graphics
11 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
In today’s marketplace, launching multiple products for a common therapeutic area is costly and challenging. This benchmark study probes how to most efficiently manage multiple products and indications in the same therapeutic area. One way franchise managers maximize the value of portfolio assets is by reducing the average cost of supporting each product.
The greatest factor affecting the cost of supporting any pharma product is sustaining a sales force. This study examines how an integrated product franchise approach can cut costs through sales force effectiveness. The study examines what aspects of sales operations can create savings through a franchise approach. The study also touches on leveraging marketing resources and visual aid/collateral integration under a product franchise approach.
This study is designed to deliver evidence-based benchmarks on sales force efficiencies that come with a franchise approach to managing multiple products.
Consumer Products; Diagnostic; Pharmaceutical; Medical Device; Biopharmaceutical; Health Care; Biotech; Market Research; Utilities; Chemical; Clinical Research; Laboratories
Bayer Healthcare; Shionogi Inc.; Roche Diagnostics; Mylan; GlaxoSmithKline ; Drager; CareFusion; B.Braun; Astellas; Entelos; Alcon; Siren Interactive; AstraZeneca; Nonin; Menarini Group; Hikma; Novartis; Nico ; Lupin; Centurion; Covidien; Galpha Laboratories; Catalent Pharma Solutions; Genentech; Almirall; Abbott; Sandoz; Johnson & Johnson; Dr Reddy's Laboratories; Merck; Meda Pharmaceuticals; Sanofi; Amylin; Teva Pharmaceutical Industries Ltd; Glenmark; Boehringer Ingelheim; Wockhardt; Novo Nordisk; Ranbaxy; Daiichi Pharmaceutical Co.; Ltd.; Roche; Baxter Healthcare; Medtronic; Shire; UCB Pharma; Stryker; Gilead Sciences; Biogen Idec; Boston Scientific; Zydus Cadila; Janssen; cipla
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.